دورية أكاديمية

Clinical Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Relative to Delta in British Columbia, Canada: A Retrospective Analysis of Whole-Genome Sequenced Cases.

التفاصيل البيبلوغرافية
العنوان: Clinical Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Relative to Delta in British Columbia, Canada: A Retrospective Analysis of Whole-Genome Sequenced Cases.
المؤلفون: Harrigan, Sean P, Wilton, James, Chong, Mei, Abdia, Younathan, Garcia, Hector Velasquez, Rose, Caren, Taylor, Marsha, Mishra, Sharmistha, Sander, Beate, Hoang, Linda, Tyson, John, Krajden, Mel, Prystajecky, Natalie, Janjua, Naveed Z, Sbihi, Hind
المصدر: Clinical Infectious Diseases; 2/1/2023, Vol. 76 Issue 3, pe18-e25, 8p
مصطلحات موضوعية: LENGTH of stay in hospitals, INTENSIVE care units, COVID-19, GENETIC mutation, SEQUENCE analysis, CONFIDENCE intervals, MULTIVARIATE analysis, RETROSPECTIVE studies, ACQUISITION of data, SEVERITY of illness index, GENOME-wide association studies, MEDICAL records, DESCRIPTIVE statistics, HOSPITAL care, RESEARCH funding, LONGITUDINAL method, PROPORTIONAL hazards models, EVALUATION
مصطلحات جغرافية: BRITISH Columbia
مستخلص: Background In late 2021, the Omicron severe acute respiratory syndrome coronavirus 2 variant emerged and rapidly replaced Delta as the dominant variant. The increased transmissibility of Omicron led to surges in case rates and hospitalizations; however, the true severity of the variant remained unclear. We aimed to provide robust estimates of Omicron severity relative to Delta. Methods This retrospective cohort study was conducted with data from the British Columbia COVID-19 Cohort, a large provincial surveillance platform with linkage to administrative datasets. To capture the time of cocirculation with Omicron and Delta, December 2021 was chosen as the study period. Whole-genome sequencing was used to determine Omicron and Delta variants. To assess the severity (hospitalization, intensive care unit [ICU] admission, length of stay), we conducted adjusted Cox proportional hazard models, weighted by inverse probability of treatment weights (IPTW). Results The cohort was composed of 13 128 individuals (7729 Omicron and 5399 Delta). There were 419 coronavirus disease 2019 hospitalizations, with 118 (22%) among people diagnosed with Omicron (crude rate = 1.5% Omicron, 5.6% Delta). In multivariable IPTW analysis, Omicron was associated with a 50% lower risk of hospitalization compared with Delta (adjusted hazard ratio [aHR] = 0.50, 95% confidence interval [CI] = 0.43 to 0.59), a 73% lower risk of ICU admission (aHR = 0.27, 95% CI = 0.19 to 0.38), and a 5-day shorter hospital stay (aß = −5.03, 95% CI = −8.01 to −2.05). Conclusions Our analysis supports findings from other studies that have demonstrated lower risk of severe outcomes in Omicron-infected individuals relative to Delta. [ABSTRACT FROM AUTHOR]
Copyright of Clinical Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:10584838
DOI:10.1093/cid/ciac705